Items where Author is "Kraenzlin, M. E."

2014

Meier, C. and Kraenzlin, C. and Friederich, N. F. and Wischer, T. and Grize, L. and Meier, C. R. and Kraenzlin, M. E.. (2014) Effect of ibandronate on spontaneous osteonecrosis of the knee : a randomized, double-blind, placebo-controlled trial. Osteoporosis international, Vol. 25, no. 1. pp. 359-366.

2009

Meier, C. and Bodmer, M. and Meier, C. R. and Kraenzlin, M. E.. (2009) [Thiazolidinediones and skeletal health]. Revue médicale suisse, Vol. 5, H. 207 , S. 1309-1310, 1312-1313.

2008

Meier, C. and Kraenzlin, M. E. and Bodmer, M. and Jick, S. S. and Jick, H. and Meier, C. R.. (2008) Use of thiazolidinediones and fracture risk. Archives of internal medicine, Vol. 168. pp. 820-825.

Kraenzlin, M. E. and Anliker, M. and Griesmacher, A.. (2008) [Laboratory assessment of osteoporosis]. Therapeutische Umschau, Vol. 65, H. 9. pp. 513-518.

1990

Keller, U. and Kraenzlin, M. E. and Gratwohl, A. and Thelin, A. and Straumann, E. and Arnaud, M. J. and Speck, B. and Stauffacher, W.. (1990) Protein metabolism assessed by 1-13C leucine infusions in patients undergoing bone marrow transplantation. Journal of parenteral and enteral nutrition, Vol. 14, H. 5. pp. 480-484.

1989

Kraenzlin, M. E. and Keller, U. and Keller, A. and Thelin, A. and Arnaud, M. J. and Stauffacher, W.. (1989) Elevation of plasma epinephrine concentrations inhibits proteolysis and leucine oxidation in man via beta-adrenergic mechanisms. Journal of Clinical Investigation, Vol. 84, H. 2. pp. 388-393.